Christiane Gueudet

1.5k total citations
23 papers, 1.1k citations indexed

About

Christiane Gueudet is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Christiane Gueudet has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cellular and Molecular Neuroscience, 21 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in Christiane Gueudet's work include Receptor Mechanisms and Signaling (21 papers), Neuropeptides and Animal Physiology (17 papers) and Neuroscience and Neuropharmacology Research (6 papers). Christiane Gueudet is often cited by papers focused on Receptor Mechanisms and Signaling (21 papers), Neuropeptides and Animal Physiology (17 papers) and Neuroscience and Neuropharmacology Research (6 papers). Christiane Gueudet collaborates with scholars based in France and Australia. Christiane Gueudet's co-authors include Martine Poncelet, Philippe Soubrié, D. Gully, Vincent Santucci, Michel Héaulme, Robert Boigegrain, Aline Brouard, Roger Leyris, R. Steinberg and G. Le Fur and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Christiane Gueudet

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christiane Gueudet France 17 898 813 156 126 126 23 1.1k
Mona Boules United States 24 1.0k 1.1× 923 1.1× 69 0.4× 156 1.2× 141 1.1× 43 1.3k
Pamela Greengrass United Kingdom 14 371 0.4× 444 0.5× 76 0.5× 122 1.0× 59 0.5× 21 974
François P. Monnet France 23 1.2k 1.3× 1.4k 1.8× 106 0.7× 121 1.0× 32 0.3× 42 2.0k
Siegfried Wurster Finland 19 594 0.7× 534 0.7× 47 0.3× 149 1.2× 129 1.0× 30 1.0k
A.T. McKnight United Kingdom 25 1.3k 1.5× 1.1k 1.4× 65 0.4× 399 3.2× 73 0.6× 58 1.6k
P J Vaysse United States 9 774 0.9× 629 0.8× 112 0.7× 123 1.0× 21 0.2× 13 1.1k
Charles E. Spivak United States 17 561 0.6× 646 0.8× 133 0.9× 57 0.5× 36 0.3× 34 1.1k
P. Boden United Kingdom 20 1.1k 1.2× 918 1.1× 36 0.2× 174 1.4× 52 0.4× 35 1.5k
Marie‐Claude Burgevin France 14 492 0.5× 464 0.6× 53 0.3× 105 0.8× 49 0.4× 24 750
Jean‐Claude Martel Canada 16 656 0.7× 449 0.6× 33 0.2× 61 0.5× 114 0.9× 17 790

Countries citing papers authored by Christiane Gueudet

Since Specialization
Citations

This map shows the geographic impact of Christiane Gueudet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christiane Gueudet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christiane Gueudet more than expected).

Fields of papers citing papers by Christiane Gueudet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christiane Gueudet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christiane Gueudet. The network helps show where Christiane Gueudet may publish in the future.

Co-authorship network of co-authors of Christiane Gueudet

This figure shows the co-authorship network connecting the top 25 collaborators of Christiane Gueudet. A scholar is included among the top collaborators of Christiane Gueudet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christiane Gueudet. Christiane Gueudet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pichat, Philippe, Olivier Bergis, Jean-Paul Terranova, et al.. (2006). SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (II) Efficacy in Experimental Models Predictive of Activity Against Cognitive Symptoms of Schizophrenia. Neuropsychopharmacology. 32(1). 17–34. 207 indexed citations
2.
Claustre, Y., Philippe Brun, Christiane Gueudet, et al.. (2003). SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. I: Neurochemical and Electrophysiological Profile. Neuropsychopharmacology. 28(12). 2064–2076. 41 indexed citations
3.
Emonds‐Alt, Xavier, Vincenzo Proietto, R. Steinberg, et al.. (2002). Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist. Canadian Journal of Physiology and Pharmacology. 80(5). 482–488. 26 indexed citations
4.
Gueudet, Christiane, et al.. (2000). Effects of neurotensin receptor antagonists on the firing rate of rat ventral pallidum neurons. Neuroreport. 11(7). 1437–1441. 12 indexed citations
5.
6.
Alonso, Richard, M. Arnone, Robert Boigegrain, et al.. (1999). SR146131: A New Potent, Orally Active, and Selective Nonpeptide Cholecystokinin Subtype 1 Receptor Agonist. II: In Vivo Pharmacological Characterization. Journal of Pharmacology and Experimental Therapeutics. 289(2). 752–761. 25 indexed citations
7.
8.
9.
Gueudet, Christiane, Vincent Santucci, Murielle Rinaldi‐Carmona, Philippe Soubrié, & Gérard Le Fur. (1995). The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat. Neuroreport. 6(10). 1421–1425. 41 indexed citations
10.
Poncelet, Martine, et al.. (1994). Turning behavior induced by intrastriatal injection of neurotensin in mice: sensitivity to non-peptide neurotensin antagonists. Naunyn-Schmiedeberg s Archives of Pharmacology. 349(1). 57–60. 31 indexed citations
11.
Poncelet, Martine, J. Souilhac, Christiane Gueudet, et al.. (1994). Effects of SR 48692, a selective non-peptide neurotensin receptor antagonist, on two dopamine-dependent behavioural responses in mice and rats. Psychopharmacology. 116(2). 237–241. 25 indexed citations
12.
Jung, M., Jeanne Maruani, J. Souilhac, et al.. (1994). Neuropharmacological characterization of SR 140333, a non peptide antagonist of NK1 receptors. Neuropharmacology. 33(2). 167–179. 52 indexed citations
13.
Poncelet, Martine, Christiane Gueudet, Xavier Emonds‐Alt, et al.. (1993). Turning behavior induced in mice by a neurokinin A receptor agonist: Stereoselective blockade by SR 48968, a non-peptide receptor antagonist. Neuroscience Letters. 149(1). 40–42. 26 indexed citations
14.
Santucci, Vincent, et al.. (1993). The NK2 receptor antagonist SR48968 inhibits thalamic responses evoked by thermal but not mechanical nociception. European Journal of Pharmacology. 237(1). 143–146. 27 indexed citations
15.
Steinberg, R., Florence Oury-Donat, Jean-Paul Terranova, et al.. (1993). SR 46559A: a novel and potent muscarinic compound with no cholinergic syndrome. Psychopharmacology. 112(2-3). 219–227. 8 indexed citations
16.
Poncelet, Martine, Vincent Santucci, Raymond Paul, et al.. (1993). Neuropharmacological profile of a novel and selective ligand of the sigma site: SR 31742A. Neuropharmacology. 32(6). 605–615. 34 indexed citations
17.
Poncelet, Martine, M. Arnone, Michel Héaulme, et al.. (1993). Neurobehavioural effects of SR 27897, a selective cholecystokinin type A (CCK-A) receptor antagonist. Naunyn-Schmiedeberg s Archives of Pharmacology. 348(1). 102–107. 23 indexed citations
18.
Mendre, Christiane, Marc Rodriguez, Marie‐Christine Galas, et al.. (1990). Pharmacological activity of cholecystokinin analogues modified in the Met28-Gly29 region. European Journal of Pharmacology. 186(2-3). 213–222. 5 indexed citations
19.
Worms, P., et al.. (1989). Systemic injection of pirenzepine induces a deficit in passive avoidance learning in rats. Psychopharmacology. 98(2). 286–288. 27 indexed citations
20.
Mendre, Christiane, Christiane Gueudet, Marie‐Christine Galas, et al.. (1988). A pseudopeptide that is a potent cholecystokinin agonist in the peripheral system is able to inhibit the dopamine-like effects of cholecystokinin in the striatum.. Journal of Biological Chemistry. 263(22). 10641–10645. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mona Boules Breakdown of academic impact, for papers by Pamela Greengrass Breakdown of academic impact, for papers by François P. Monnet Breakdown of academic impact, for papers by Siegfried Wurster Breakdown of academic impact, for papers by A.T. McKnight Breakdown of academic impact, for papers by P J Vaysse Breakdown of academic impact, for papers by Charles E. Spivak Breakdown of academic impact, for papers by P. Boden Breakdown of academic impact, for papers by Marie‐Claude Burgevin Breakdown of academic impact, for papers by Jean‐Claude Martel
Rankless by CCL
2026